PTC Therapeutics, Inc.

PTCTNASDAQUSD
70.85 USD
1.64 (2.37%)AT CLOSE (11:59 AM EDT)
70.86
0.01 (0.01%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
70.86
0.01 (0.01%)
🔴Market: CLOSED

Shares of PTC Therapeutics, Inc. (PTCT) are trading at $70.86. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (23.2%) and a bullish Golden Cross on the moving averages. PTCT is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Aug 6, 2026.

Open?$68.99
High?$71.04
Low?$68.99
Prev. Close?$69.21
Volume?928.9K
Avg. Volume?1.9M
VWAP?$70.34
Rel. Volume?0.48x
Bid / Ask
Bid?$60.79 × 100
Ask?$83.79 × 100
Spread?$23.00
Midpoint?$72.29
Valuation & Ratios
Market Cap?5.8B
Shares Out?83.5M
Float?78.8M
Float %?95.0%
P/E Ratio?N/A
P/B Ratio?-34.93
EPS?-$0.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Employees
991
Market Cap
5.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2013-06-20
Address
500 WARREN CORPORATE CENTER DRIVE
WARREN, NJ 07059
Phone: (908) 222-7000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
9
Momentum?
85
Short Sent.?
70
Piotroski F-Score?4/9Mixed
Altman Z-Score?0.89Distress
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.48%High
Short Interest?9.8M
Days to Cover?4.8
Free Float78.8M
Avg Daily Volume2.1M
Settlement Date2026-07-15
Financial Health
Current Ratio?3.39Strong
Quick Ratio?3.28Strong
Cash Ratio?1.36Strong
Debt/Equity?-3.61Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
S&P
97
-34.93CHEAP
P/S?
Peers
100
S&P
24
5.73FAIR
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
9
30.8HIGH
EV/Sales?
Peers
100
S&P
34
5.28FAIR
Returns & Efficiency
ROE?
Peers
50
S&P
72
23.2%STRONG
ROA?
S&P
3
-1.2%WEAK
Cash Flow & Enterprise
FCF?$-39711000
Enterprise Value?$5.3B
Fundamentals ratios updated end of day